Synergistic treatment of cells that express EphA2 and ErbB2

Details for Australian Patent Application No. 2008265928 (hide)

Owner MedImmune, LLC Vanderbilt University

Inventors Bruckheimer, Elizabeth; Jackson, Dowdy; Brantley-Sieders, Dana; Chen, Jin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008265928

PCT Pub. Number WO2008/157490

Priority 60/929,212 18.06.07 US

Filing date 16 June 2008

Wipo publication date 24 December 2008

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/157490 Priority application(s): WO2008/157490

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008265930-Lyophilized immunoglobulin formulations and methods of preparation

2008265912-Method and apparatus for geobaric analysis